Date: 5/30/2025
Overview:
Stay up-to-date with Wunderkind’s latest product enhancements, new features, and optimizations across the Autonomous Marketing Platform. These release notes provide a snapshot of what is new, helping you maximize the value of Wunderkind’s solutions. For additional details or support, please reach out to your Wunderkind representative.
Updates:
Feature | Description | General Availability Date |
MSDK 2.2.1 |
|
5/21/2025 |
Text: Static Audio MMS for Behavioral Text messages | Added Static Audio option for Behavioral MMS Text messages | 5/22/2025 |
Studio: Block Duplication | Studio blocks now support multiple versions, allowing users to create variations of templatized blocks for different strategies. | 5/29/2025 |
Studio: Selective Block Publishing | Studio blocks now let users choose which sections to overwrite—content, design, advanced settings, or any combination. | 5/23/2025 |
Studio: Editor Redesign | The email editor has been redesigned for a simpler experience and improved usability on smaller screens. | 5/7/2025 |
Segmentation: Real-time audience counts | Clients will see the number of eligible subscribers update instantly as they edit or change segment criteria. | 5/30/2025 |
Improvements:
-
Studio
- Previews now update on blur or Enter, reducing flicker and aligning with design tool best practices for a smoother experience.
Bug Fixes:
-
Studio
- Fixed issue where the user could not set the percentage width on an image.
Betas:
Feature | Description | Status |
Text: For On-demand local timezone text sends, we default to the timezone detected from the user's last visit. | We now default to using the timezone from the user's most recent visit event for On-demand local timezone sends. If the last visit data is older than 90 days or appears inaccurate—such as being recorded outside the user’s mainland country—we instead default to the timezone based on the user’s phone area and country code. | Beta iteration |
Support:
For any issues, please submit a ticket on our Support Portal.
Comments
0 comments
Please sign in to leave a comment.